Muvalaplin significantly lowered lipoprotein(a) levels, reducing the risk of cardiovascular events in high-risk adults.

The financing round will fund the improvement of the company’s technology platform for the discovery and development of ...

Genesis Therapeutics has secured $200 million funding from NVentures, NVIDIA’s venture capital arm. This forms part of an expanded partnership to enhance Genesis’ AI-powered drug discovery platform, ...

AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it unveils a $3.5 billion infusion into US sites.

AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...

Results from the SURMOUNT-1 trial show that weekly injections of tirzepatide could stop the progression from pre-diabetes to ...

Pharmacokinetic (PK) tests form an integral part of the drug development process, helping to ensure the safety and efficacy ...